Melflufen therapy for relapsed refractory multiple myeloma (RRMM) patients refractory to daratumumab and/or pomalidomide: A report on early efficacy Meeting Abstract
| Authors: | Mateos, M. V.; Bladé, J.; Larocca, A.; Oriol, A.; Rodriguez, P.; Alegre, A.; Cavo, M.; Moreb, J. S.; Paner, A.; Gabrail, N.; Halka, K. G.; Hassoun, H.; Maisel, C.; Mazumder, A.; Zonder, J. A.; Ocio, E. M.; Byrne, C.; Harmenberg, J.; Thuresson, S.; Nordstrom, E.; Lindberg, J.; Richardson, P. G. |
| Abstract Title: | Melflufen therapy for relapsed refractory multiple myeloma (RRMM) patients refractory to daratumumab and/or pomalidomide: A report on early efficacy |
| Meeting Title: | 59th Annual Meeting of the American Society of Hematology (ASH) |
| Journal Title: | Blood |
| Volume: | 130 |
| Issue: | Suppl. 1 |
| Meeting Dates: | 2017 Dec 9-12 |
| Meeting Location: | Atlanta, GA |
| ISSN: | 0006-4971 |
| Publisher: | American Society of Hematology |
| Date Published: | 2017-12-07 |
| Language: | English |
| ACCESSION: | WOS:000432419404285 |
| PROVIDER: | wos |
| DOI: | 10.1182/blood.V130.Suppl_1.1841.1841 |
| Notes: | Meeting Abstract: 1841 -- Source: Wos |
